The Gross Margin of Taiko Pharmaceutical Co Ltd (4574.T) is 58.26%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 58.26% |
| 2023-12-31 | 42.11% |
| 2022-12-31 | 21.41% |
| 2021-12-31 | 29.44% |
| 2020-12-31 | 70.07% |
| 2020-03-31 | 70.88% |
| 2019-03-31 | 69.13% |
| 2018-03-31 | 69.49% |
| 2017-03-31 | 67.28% |
| 2016-03-31 | 69.30% |